Unicycive Therapeutics, Inc. (UNCY) Q2 2024 Earnings
UNCY·Reported August 14, 2024·Before market open
Diluted EPS came in at $-0.15, beat the $-0.23 consensus by $0.08.
Diluted EPS
$-0.15beat by $0.08
Consensus: $-0.23
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Unicycive Therapeutics, Inc.'s Q2 2024 earnings report.
Unicycive Therapeutics, Inc. (UNCY) reported Q2 2024 earnings on August 14, 2024 before market open.
Unicycive Therapeutics, Inc. reported diluted EPS of $-0.15 for Q2 2024.
EPS beat the consensus estimate of $-0.23 by $0.08.
You can read the 10-Q periodic report (0001213900-24-068565) directly on SEC EDGAR. The filing index links above go to sec.gov.